Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 60,980 | |||
2 |  STARTUP | Avg patent value: 27,000 | ||
3 | Psychedelic drug | Avg patent value: 27,000 | ||
4 |  STARTUP | Avg patent value: 15,000 | ||
5 | Avg patent value: 0 |
Top 5 Key Players companies in Psilocybin
by Highest Patent Value in the Canada in 2018
The Psilocybin top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Psilocybin Key Players in the Canada. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Psilocybin (/ˌsaɪləˈsaɪbɪn/ sy-lə-SY-bin) is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. As a prodrug, psilocybin is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT. In general, the effects include euphoria, visual and mental hallucinations, changes in perception, a distorted sense of time, spiritual experiences, and can include possible adverse reactions such as nausea and panic attacks.
Page generation time:
Jun 21 2025